Considering the urgency of the ongoing COVID-19 pandemic, detection of various new mutant strains and future potential re-emergence of novel coronaviruses, repurposing of approved drugs such as Ivermectin could be worthy of attention. This evidence-based review article aims to discuss the mechanism of action of ivermectin against SARS-CoV-2 and summarizing the available literature over the years. A schematic of the key cellular and biomolecular interactions between Ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications have been proposed.
Glad to announce that our Evidence-based clinical review article- Mechanisms of action of Ivermectin against SARS-CoV-2 has been published in Springer Nature
Click on this link to read the article
We hope this manuscript would improve the knowledge around the so debated “I” drug.
On behalf of Associazione Naso Sano
Dr. Asiya Kamber Zaidi & Dr. Puya Dehgani Mobaraki
0 commenti su “Meccanismi di azione dell’ Ivermectina – An evidence-based clinical review article published on the Journal of Antibiotics 15 June 2021”